Dr. Mohamedtaki A. Tejani
Claim this profileAdventHealth Orlando
Area of expertise
Pancreatic Cancer
Mohamedtaki A. Tejani has run 4 trials for Pancreatic Cancer. Some of their research focus areas include:
Colorectal Cancer
Mohamedtaki A. Tejani has run 3 trials for Colorectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
AdventHealth Orlando
AdventHealth Altamonte
Clinical Trials Mohamedtaki A. Tejani is currently running
Nivolumab + Standard Treatment
for Stomach and Esophageal Cancer
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
Recruiting
1 award
Phase 2 & 3
20 criteria
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting
0 awards
Phase 2
32 criteria
More about Mohamedtaki A. Tejani
Clinical Trial Related
4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Mohamedtaki A. Tejani has experience with
- Nivolumab
- Oxaliplatin
- Paclitaxel
- Fluorouracil
- Carboplatin
- Ipilimumab
Breakdown of trials Mohamedtaki A. Tejani has run
Pancreatic Cancer
Colorectal Cancer
Colon Cancer
Bile Duct Cancer
Pancreatic Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamedtaki A. Tejani specialize in?
Mohamedtaki A. Tejani focuses on Pancreatic Cancer and Colorectal Cancer. In particular, much of their work with Pancreatic Cancer has involved BRCA1 positive patients, or patients who are BRCA2 positive.
Is Mohamedtaki A. Tejani currently recruiting for clinical trials?
Yes, Mohamedtaki A. Tejani is currently recruiting for 4 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Mohamedtaki A. Tejani has studied deeply?
Yes, Mohamedtaki A. Tejani has studied treatments such as Nivolumab, Oxaliplatin, Paclitaxel.
What is the best way to schedule an appointment with Mohamedtaki A. Tejani?
Apply for one of the trials that Mohamedtaki A. Tejani is conducting.
What is the office address of Mohamedtaki A. Tejani?
The office of Mohamedtaki A. Tejani is located at: AdventHealth Orlando, Orlando, Florida 32803 United States. This is the address for their practice at the AdventHealth Orlando.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.